GUAIFENESIN 200MG- guaifenesin tablet 
Marlex Pharmaceuticals Inc

----------

Guaifenesin 200mg Tablets

GUAIFENESIN 200 MG TABLETS

MarlexPharmaceuticals, Inc.

----------

Drug Fact

Active ingredient (in each tablet)

Guaifenesin 200mg

Purpose

Expectorant

Guaifenesin 200 mg Tablets

Uses

helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageway of bothersome mucus and make coughs more productive

Warnings

Ask a doctor before use if you have

Stop use and ask a doctor if

cough last more than 7 days, comes back or is accompanied by fever, rash, or persistent headache. There could be signs of a serious illness.

TAMPER EVIDENT: DO NOT USE IF IMPRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

If pregnant or breast- feeding,

ask a health professional before use.

Keep out of reach of children.

In case of overdose, get medical help or contact a Poison Control Center right away.

Directions:

Other Information:

Inactive Ingredients:

maltodextrin, povidone, silicon dioxide, stearic acid.

Manufactured for/ Distributed by:

Marlex Pharmaceuticals, Inc.

New Castle, DE 19720

Rev. 03/24 AA

PRINCIPAL DISPLAY PANEL

NDC 10135-0789-01
Guaifenesin
200 mg
100 TABLETS

789-01

GUAIFENESIN 200MG 
guaifenesin tablet
Product Information
Product TypeHUMAN OTC DRUGItem Code (Source)NDC:10135-789
Route of AdministrationORAL
Active Ingredient/Active Moiety
Ingredient NameBasis of StrengthStrength
GUAIFENESIN (UNII: 495W7451VQ) (GUAIFENESIN - UNII:495W7451VQ) GUAIFENESIN200 mg
Inactive Ingredients
Ingredient NameStrength
SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
MALTODEXTRIN (UNII: 7CVR7L4A2D)  
POVIDONE (UNII: FZ989GH94E)  
STEARIC ACID (UNII: 4ELV7Z65AP)  
Product Characteristics
Colorwhite (White to off white) Scoreno score
ShapeROUNDSize8mm
FlavorImprint Code C15
Contains    
Packaging
#Item CodePackage DescriptionMarketing Start DateMarketing End Date
1NDC:10135-789-01100 in 1 BOTTLE; Type 0: Not a Combination Product03/01/2024
Marketing Information
Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
OTC Monograph DrugM01203/01/2024
Labeler - Marlex Pharmaceuticals Inc (782540215)

Revised: 3/2024
Document Id: 13b8fd80-a10a-dad6-e063-6394a90afdcb
Set id: 13b8f480-d1ac-d70c-e063-6394a90ab4f4
Version: 1
Effective Time: 20240315
 
Marlex Pharmaceuticals Inc